REPROS THERAPEUTICS INC's ticker is RPRX and the CUSIP is 76028H209. A total of 81 filers reported holding REPROS THERAPEUTICS INC in Q2 2013. The put-call ratio across all filers is 1.16 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2013 | $927,000 | – | 50,268 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SPHERA FUNDS MANAGEMENT LTD. | 778,800 | $935,000 | 0.18% |
| Allegis Investment Advisors, LLC | 366,190 | $439,000 | 0.12% |
| GENERAL AMERICAN INVESTORS CO INC | 589,768 | $708,000 | 0.07% |
| Acrospire Investment Management LLC | 24,881 | $30,000 | 0.02% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 114,165 | $137,000 | 0.00% |
| Mariner Wealth Advisors-Cincinnati, LLC | 11,000 | $13,000 | 0.00% |
| Renaissance Technologies | 727,113 | $873,000 | 0.00% |
| BALDWIN BROTHERS LLC/MA | 1,750 | $2,000 | 0.00% |
| VANGUARD GROUP INC | 889,850 | $1,068,000 | 0.00% |
| LADENBURG THALMANN FINANCIAL SERVICES INC. | 150 | $0 | 0.00% |